J Clin Microbiol. 1992 November; 30(11): 2881-2886
Susceptibility testing of Cryptococcus neoformans: a microdilution technique.
M A Ghannoum,
A S Ibrahim,
Y Fu,
M C Shafiq,
J E Edwards Jr and
R S Criddle
Department of Medicine, Harbor-UCLA Medical Center, Torrance 90509.
ABSTRACT
We studied a series of test conditions in a microtiter system to define the optimal method for determining the susceptibility of Cryptococcus neoformans to antifungal agents. Twenty-one isolates of C. neoformans were grown for 24 or 48 h in four chemically defined media: yeast nitrogen base (BYNB 7); RPMI 1640; synthetic amino acid medium--fungal (SAAMF), buffered at pH 7.0 to select the medium that best supported growth of this fastidious yeast; and yeast nitrogen base, pH 5.4 (YNB 5.4). Maximum growth of C. neoformans, at 35 degrees C, was obtained in YNB 5.4, with the next highest growth levels in BYNB 7, SAAMF, and RPMI. Growth at 24 h was uniformly poor in all media and lacked reproducibility. In contrast, incubation for 48 h gave adequate growth with low standard deviations, and 48 h was selected as the optimal incubation period for this study. Comparison of the relationship between growth kinetics and initial inoculum size for eight cryptococcal isolates showed that 10(4) cells per ml yielded optimal growth in BYNB 7 and YNB 5.4, whereas 10(5) cells per ml was optimal in RPMI and SAAMF. Furthermore, variation of inocula from 10(3) to 10(5) cells per ml showed small but significant inoculum effects in determining MICs of fluconazole, amphotericin B, and flucytosine for C. neoformans. Therefore, 10(4) cells per ml was chosen as the optimal inoculum for susceptibility testing in this study. Mean MICs of fluconazole, amphotericin B, and flucytosine for 21 crytococcal isolates in RPMI and BYNB 7 were low (for example, fluconazole had mean MICs of 1.2 and 1.3 micrograms/ml in RPMI and BYNB 7, respectively) and differed significantly from medium to medium. In contrast, the MICs obtained in SAAMF were significantly higher (e.g., fluconazole had a mean MIC of 2.2 micrograms/ml). Variance in MICs was large with fluconazole and flucytosine but small with amphotericin B, irrespective of the medium used. A microtiter system employing BYNB 7 as the medium, 48 h as the incubation period, and 10(4) cells per ml as the final inoculum is a simple, accurate, and reproducible method for the testing of C. neoformans susceptibility to fluconazole, amphotericin B, and flucytosine.
J Clin Microbiol. 1992 November; 30(11): 2881-2886
This article has been cited by other articles:
-
Khan, Z. U., Randhawa, H. S., Kowshik, T., Chowdhary, A., Chandy, R.
(2007). Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in north-western India. J Antimicrob Chemother
60: 312-316
[Abstract]
[Full Text]
-
Dias, A. L. T., Matsumoto, F. E., Melhem, M. S. C., da Silva, E. G., Auler, M. E., de Siqueira, A. M., Paula, C. R.
(2006). Comparative analysis of Etest and broth microdilution method (AFST-EUCAST) for trends in antifungal drug susceptibility testing of Brazilian Cryptococcus neoformans isolates.. J Med Microbiol
55: 1693-1699
[Abstract]
[Full Text]
-
Dannaoui, E., Abdul, M., Arpin, M., Michel-Nguyen, A., Piens, M. A., Favel, A., Lortholary, O., Dromer, F., the French Cryptococcosis Study Group,
(2006). Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.. Antimicrob. Agents Chemother.
50: 2464-2470
[Abstract]
[Full Text]
-
Perkins, A., Gomez-Lopez, A., Mellado, E., Rodriguez-Tudela, J. L., Cuenca-Estrella, M.
(2005). Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans. J Antimicrob Chemother
56: 1144-1147
[Abstract]
[Full Text]
-
Pascon, R. C., Ganous, T. M., Kingsbury, J. M., Cox, G. M., McCusker, J. H.
(2004). Cryptococcus neoformans methionine synthase: expression analysis and requirement for virulence. Microbiology
150: 3013-3023
[Abstract]
[Full Text]
-
Ganendren, R., Widmer, F., Singhal, V., Wilson, C., Sorrell, T., Wright, L.
(2004). In Vitro Antifungal Activities of Inhibitors of Phospholipases from the Fungal Pathogen Cryptococcus neoformans. Antimicrob. Agents Chemother.
48: 1561-1569
[Abstract]
[Full Text]
-
Ramos, J. M., Cuenca-Estrella, M., Gutierrez, F., Elia, M., Rodriguez-Tudela, J. L.
(2004). Clinical Case of Endocarditis due to Trichosporon inkin and Antifungal Susceptibility Profile of the Organism. J. Clin. Microbiol.
42: 2341-2344
[Abstract]
[Full Text]
-
Gadea, I., Cuenca-Estrella, M., Prieto, E., Diaz-Guerra, T. M., Garcia-Cia, J. I., Mellado, E., Tomas, J. F., Rodriguez-Tudela, J. L.
(2004). Genotyping and Antifungal Susceptibility Profile of Dipodascus capitatus Isolates Causing Disseminated Infection in Seven Hematological Patients of a Tertiary Hospital. J. Clin. Microbiol.
42: 1832-1836
[Abstract]
[Full Text]
-
Bartlett, K., Yau, E., Hartsel, S. C., Hamer, A., Tsai, G., Bizzotto, D., Wasan, K. M.
(2004). Effect of Heat-Treated Amphotericin B on Renal and Fungal Cytotoxicity. Antimicrob. Agents Chemother.
48: 333-336
[Abstract]
[Full Text]
-
van Duin, D., Casadevall, A., Nosanchuk, J. D.
(2002). Melanization of Cryptococcus neoformans and Histoplasma capsulatum Reduces Their Susceptibilities to Amphotericin B and Caspofungin. Antimicrob. Agents Chemother.
46: 3394-3400
[Abstract]
[Full Text]
-
Brandt, M. E., Pfaller, M. A., Hajjeh, R. A., Hamill, R. J., Pappas, P. G., Reingold, A. L., Rimland, D., Warnock, D. W.
(2001). Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob. Agents Chemother.
45: 3065-3069
[Abstract]
[Full Text]
-
Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Warnock, D. W.
(2001). Antifungal Susceptibility Testing: Practical Aspects and Current Challenges. Clin. Microbiol. Rev.
14: 643-658
[Abstract]
[Full Text]
-
Meletiadis, J., Meis, J. F. G. M., Mouton, J. W., Verweij, P. E.
(2001). Analysis of Growth Characteristics of Filamentous Fungi in Different Nutrient Media. J. Clin. Microbiol.
39: 478-484
[Abstract]
[Full Text]
-
Aller, A. I., Martin-Mazuelos, E., Gutierrez, M. J., Bernal, S., Chavez, M., Recio, F. J.
(2000). Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents. J Antimicrob Chemother
46: 997-1000
[Abstract]
[Full Text]
-
Ramani, R., Chaturvedi, V.
(2000). Flow Cytometry Antifungal Susceptibility Testing of Pathogenic Yeasts other than Candida albicans and Comparison with the NCCLS Broth Microdilution Test. Antimicrob. Agents Chemother.
44: 2752-2758
[Abstract]
[Full Text]
-
Hahn, R. C., Hamdan, J. S.
(2000). Effects of Amphotericin B and Three Azole Derivatives on the Lipids of Yeast Cells of Paracoccidioides brasiliensis. Antimicrob. Agents Chemother.
44: 1997-2000
[Abstract]
[Full Text]
-
Aller, A. I., Martin-Mazuelos, E., Lozano, F., Gomez-Mateos, J., Steele-Moore, L., Holloway, W. J., Gutiérrez, M. J., Recio, F. J., Espinel-Ingroff, A.
(2000). Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection. Antimicrob. Agents Chemother.
44: 1544-1548
[Abstract]
[Full Text]
-
Lopez-Jodra, O., Torres-Rodriguez, J. M., Mendez-Vasquez, R., Ribas-Forcadell, E., Morera-Lopez, Y., Baro-Tomas, T., Alia-Aponte, C.
(2000). In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method. J Antimicrob Chemother
45: 645-649
[Abstract]
[Full Text]
-
Rodríguez-Tudela, J. L., Martín-Díez, F., Cuenca-Estrella, M., Rodero, L., Carpintero, Y., Gorgojo, B.
(2000). Influence of Shaking on Antifungal Susceptibility Testing of Cryptococcus neoformans: a Comparison of the NCCLS Standard M27A Medium, Buffered Yeast Nitrogen Base, and RPMI-2% Glucose. Antimicrob. Agents Chemother.
44: 400-404
[Abstract]
[Full Text]
-
Okeke, C. N., Tsuboi, R., Kawai, M., Ogawa, H.
(2000). Fluorometric Assessment of In Vitro Antidermatophytic Activities of Antimycotics Based on Their Keratin-Penetrating Power. J. Clin. Microbiol.
38: 489-491
[Abstract]
[Full Text]
-
Lozano-Chiu, M., Arikan, S., Paetznick, V. L., Anaissie, E. J., Rex, J. H.
(1999). Optimizing Voriconazole Susceptibility Testing of Candida: Effects of Incubation Time, Endpoint Rule, Species of Candida, and Level of Fluconazole Susceptibility. J. Clin. Microbiol.
37: 2755-2759
[Abstract]
[Full Text]
-
Mondon, P., Petter, R., Amalfitano, G., Luzzati, R., Concia, E., Polacheck, I., Kwon-Chung, K. J.
(1999). Heteroresistance to Fluconazole and Voriconazole in Cryptococcus neoformans. Antimicrob. Agents Chemother.
43: 1856-1861
[Abstract]
[Full Text]
-
Lozano-Chiu, M., Paetznick, V. L., Ghannoum, M. A., Rex, J. H.
(1998). Detection of Resistance to Amphotericin B among Cryptococcus neoformans Clinical Isolates: Performances of Three Different Media Assessed by Using E-Test and National Committee for Clinical Laboratory Standards M27-A Methodologies. J. Clin. Microbiol.
36: 2817-2822
[Abstract]
[Full Text]
-
Jessup, C. J., Pfaller, M. A., Messer, S. A., Zhang, J., Tumberland, M., Mbidde, E. K., Ghannoum, M. A.
(1998). Fluconazole Susceptibility Testing of Cryptococcus neoformans: Comparison of Two Broth Microdilution Methods and Clinical Correlates among Isolates from Ugandan AIDS Patients. J. Clin. Microbiol.
36: 2874-2876
[Abstract]
[Full Text]
Copyright © 1992 by the American Society for Microbiology. All rights reserved.